Literature DB >> 8066542

Peripheral proliferative retinopathies: an update on angiogenesis, etiologies and management.

L M Jampol1, D A Ebroon, M H Goldbaum.   

Abstract

Many clinical entities may be associated with the development of peripheral retinal neovascularization. In this paper, we review the mechanisms of normal and abnormal angiogenesis in the retina. Specific disease entities associated with peripheral proliferative retinopathies are discussed. These include vascular disease with ischemia, inflammatory diseases with possible ischemia and a variety of miscellaneous causes, including hereditary diseases and tumors. Basic principles for the clinical evaluation of patients with retinal neovascularization are described. Finally, the treatments for retinal neovascularization, including cryopexy and local and panretinal photocoagulation are reviewed, and techniques and possible mechanisms of the beneficial results of treatment are described.

Entities:  

Mesh:

Year:  1994        PMID: 8066542     DOI: 10.1016/0039-6257(94)90146-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  11 in total

1.  Idiopathic anterior hyaloid vessels.

Authors:  J G F Dowler; J S Mehta; A M Landers; A M P Hamilton
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases.

Authors:  A J Augustin; F H Grus; F Koch; M Spitznas
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

4.  Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat.

Authors:  W Y Shen; M J Yu; C J Barry; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

5.  Inhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cells.

Authors:  Chandra Shekar Boosani; Narasimharao Nalabothula; Nader Sheibani; Akulapalli Sudhakar
Journal:  Curr Eye Res       Date:  2010-01       Impact factor: 2.424

6.  Preretinal neovascularisation associated with choroidal melanoma.

Authors:  J Lee; S Logani; H Lakosha; R P Schroeder; R Simpson; L M Jampol
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

7.  Chronic systemic hypoxia causes intra-retinal angiogenesis.

Authors:  Alex J Shortt; Katherine Howell; Colm O'Brien; Paul McLoughlin
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

8.  FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1.

Authors:  Chandra S Boosani; Narasimharao Nalabothula; Veerendra Munugalavadla; Dominic Cosgrove; Venkateshwar G Keshamoun; Nader Sheibani; Akulapalli Sudhakar
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

9.  Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats.

Authors:  Nava Naveh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-30       Impact factor: 3.117

10.  Hypertension as an Unusual Cause of Proliferative Retinopathy: Case Report and Literature Review.

Authors:  Rami Hasan Saleem Abu Sbeit; Osman Abdelzaher Mohammed; Laith Ishaq Alamlih
Journal:  Case Rep Ophthalmol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.